Dr Carlos E Carbonell, - Medicare Obstetrics & Gynecology in Aguadilla, PR

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

News Archive

Consumer Health Advisers raises $1.15M to expand its sales and marketing initiatives

Consumer Health Advisers, Inc. (CHA), a pioneering provider of a personal 'electronic medical home' for employees and dependents of large companies, is pleased to announce it has completed a Series A venture capital round of $1.15 million and opened a new office in Chicago, Illinois.

CHOPS syndrome sheds light on key biological processes during human development

Analyzing a puzzling multisystem disorder in three children, genetic experts have identified a new syndrome, shedding light on key biological processes during human development. The research also provides important information to help caregivers manage the disorder, and may offer clues to eventually treating it.

Lateral inhibition avoids overlap between similar memories

When you park in the office car park, you usually have no problem finding your car again at the end of the day. The next day, you might park a few spots further away. However, in the evening, you find your car, even though the memories of both days are very similar.

Bits of plastic in Lean Cuisine meals bring recall

The recall notice was issued Tuesday by the U.S. Department of Agriculture and affects about 10,260 pounds of frozen spaghetti and meatballs. Food maker Nestle, in its statement, says the affected packages were produced in October. The health risk associated with this recall is low, the USDA's Food Safety and Inspection Service explained. If the product is consumed, there is only a remote probability of adverse health consequences.

Cel Sci completes its production facility for Multikine Phase III clinical trial

BioMedReports, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, was given an exclusive tour of CEL-SCI Corporation's, new, state-of-the-art manufacturing facility near Baltimore, MD where the potentially ground breaking cancer immunotherapy treatment, Multikine, will be manufactured to support an upcoming Phase III clinical trial.

Read more News

› Verified 3 days ago